|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2012)) |
IUPAC Name ![]() |
| 4-[(E)-2-[6-(2-{2-[2-(18F)fluoroethoxy]ethoxy}ethoxy)pyridin-3-yl]ethenyl]-N-methylaniline |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9193 | florbetapir (18F) |
Synonyms ![]() |
| AMYViD® |
| AV-45 |
| florbetapir (18F) |
Database Links ![]() |
|
| CAS Registry No. | 956103-76-7 (source: SciFinder) |
| ChEMBL Ligand | CHEMBL1774461 |
| PubChem CID | 24822371 |
| Search Google for chemical match using the InChIKey | YNDIAUKFXKEXSV-CRYLGTRXSA-N |
| Search Google for chemicals with the same backbone | YNDIAUKFXKEXSV |
| Search PubMed clinical trials | florbetapir |
| Search PubMed titles | florbetapir |
| Search PubMed titles/abstracts | florbetapir |
| Wikipedia | Florbetapir |
| Comments |
| Florbetapir F18 is a molecular imaging agent (diagnostic radiopharmaceutical) that binds to β-amyloid aggregates in Alzheimer's brains. |